Sorrento Receives US FDA Clearance to Proceed With Phase 1 Study for STI-2099 (Intranasal COVIDROPS) in Healthy Volunteers and Outpatient Treatment for Newly Diagnosed COVID-19 Positive Patients
02. März 2021 16:02 ET
|
Sorrento Therapeutics, Inc.
FDA granted IND clearance today for the commencement of a Phase 1 safety and pharmacokinetic study for STI-2099 (COVIDROPS™) in healthy volunteers and outpatients with mild COVID-19 disease with or...
Sorrento to Present Data Demonstrating STI-2020 Preserves Binding Against UK B.1.1.7 SARS-CoV-2 Mutated Spike Protein
19. Januar 2021 17:06 ET
|
Sorrento Therapeutics, Inc.
SAN DIEGO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced that it will be presenting preliminary results from an ongoing SARS-CoV-2 mutation...
Precipio’s HemeScreen™ Adopted by Methodist Health
03. April 2019 07:38 ET
|
Precipio, Inc.
NEW HAVEN, Conn., April 03, 2019 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that Methodist Hospital, located in Memphis, TN, has selected...
Precipio Expands ICE-COLD PCR™ Lung Cancer Mutation Detection Offering
20. September 2018 07:37 ET
|
Precipio, Inc.
New kit examines most relevant EGFR exons that impact therapeutic decisions for lung cancer patients NEW HAVEN, Conn., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ: PRPO), announced...
New Genetic Mutation Discovery Sheds Light on Anemia Disease
03. März 2016 12:36 ET
|
ARUP Laboratories
SALT LAKE CITY, March 3, 2016 (GLOBE NEWSWIRE) -- Using whole exome sequencing, which sequences all expressed genes in a genome, Rong Mao, MD, and Pinar Bayrak-Toydemir, MD, PhD, discovered a new...
Breakthrough Technology Spurs New Test for Non-Small Cell Lung Cancer Patients
05. November 2015 15:18 ET
|
ARUP Laboratories
SALT LAKE CITY, Nov. 5, 2015 (GLOBE NEWSWIRE) -- For a patient battling lung cancer, the discomforts and risks of undergoing repeated biopsies, surgeries, and radiologic scans can now be replaced by a...
Invivoscribe FLT3 Method Patent Claims Upheld
16. Juli 2013 00:01 ET
|
Invivoscribe
SAN DIEGO, CA--(Marketwired - Jul 16, 2013) - Invivoscribe Technologies, Inc. ("Invivoscribe") has successfully defended the method claims at the core of international patents covering FLT3...
Invivoscribe Prevails in German District Court (FLT3 Patent Infringement Action)
14. Mai 2013 00:01 ET
|
Invivoscribe Technologies, Inc.
SAN DIEGO, CA--(Marketwired - May 14, 2013) - MLL Münchner Leukämielabor GmbH ("MLL") Laboratories has been found guilty of patent infringement in a matter involving FLT3 testing patent...
Differentiation and Mutation Changes in Mammalian Cells of Shared Lineage Determined With Assay Method That Measures Multiple Energy-Producing Pathways
24. März 2011 17:30 ET
|
Biolog, Inc.
HAYWARD, CA--(Marketwire - March 24, 2011) - In a paper published today in the journal PLoS ONE, researchers from Biolog, Inc., and the Broad Institute of Harvard & MIT describe the...